跳至主要内容
临床试验/jRCT2031240672
jRCT2031240672尚未招募不适用

A double-blind comparative study of BFE1224 in patients with tinea pedis.

Sato Pharmaceutical Co., Ltd.0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
120
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Parallel Assignment
主要目的
Treatment Purpose
盲法
Double Blind

入排标准

年龄范围
18age old over 至 No limit(—)
性别
All

入选标准

  • Patients with tinea pedis in both feet or either foot.
  • Patients who have been confirmed to have dermatophyte elements by direct microscopic examination.
  • Patients in whom dermatophytes (Trichophyton species) have been identified by fungal culture.
  • Japanese patients aged 18 years or older at the time of consent.

排除标准

  • Patients with clinically significant hepatic dysfunction.
  • Patients with diseases or symptoms other than tinea pedis in the foot to be evaluated.
  • Patients who have used oral antifungal agents within 12 weeks prior to obtaining consent, or who are currently using them.
  • Patients who have used topical antifungal agents or topical treatments for onychomycosis on the foot to be evaluated within 4 weeks prior to obtaining consent, or who are currently using them.

结局指标

主要结局

-

Cure rate at 12 weeks after the start of treatment.

次要结局

未报告次要终点

研究者

相似试验